COMMUNIQUÉS West-GlobeNewswire

Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Leading Out in Developing Fresh Wave of Inhibitor Classes
25/06/2026
NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within [...]
Microbot Medical® Wins Surgical Robotics Industry Award for the LIBERTY® Endovascular Robotic System
25/06/2026
Innovative Start-Up award recognizes LIBERTY as a highly innovative, ground-breaking product with potentially wide range and/or substantial benefit HINGHAM, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc [...]
Candel Therapeutics Appoints Mark Sims as Chief Commercial Officer
25/06/2026
Appointment supports planned Biologics License Application (BLA) submission in the fourth quarter of 2026 and potential 2027 launch of aglatimagene besadenovec in localized prostate cancer NEEDHAM, Mass., June 25, 2026 [...]
Ernexa Therapeutics Launches CEO Corner to Provide Deeper Insights into Company Progress, Scientific Strategy and Vision for Patients
25/06/2026
New platform provides additional perspective on Ernexa's mission to deliver hope for patients through innovative, scalable cell therapies while improving accessibility and affordability Inaugural video highlights [...]
Oblenio Bio Closes $62 Million Series B to Advance Tri-specific T-Cell Engager LBL-051 for Autoimmune Diseases into Clinical Development
25/06/2026
-- Round led by Pfizer Ventures, with participation from Deep Track Capital, GV, and founding investor, Aditum Bio -- --LBL-051’s ability to reset the immune system is supported by recent preclinical data presented at [...]
Leads Biolabs Announces Partner Oblenio Bio’s $62 Million Oversubscribed Series B Financing to Advance Tri-Specific T-Cell Engager LBL‑051 for Autoimmune Diseases into Clinical Development
25/06/2026
NANJING, China, June 25, 2026 (GLOBE NEWSWIRE) -- Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) today announced that its partner company with Aditum Bio, Oblenio Bio (“Oblenio [...]
Young workers willing to make career trade-offs for jobs with pensions: new research from HOOPP and Abacus Data
25/06/2026
TORONTO, June 25, 2026 (GLOBE NEWSWIRE) -- In an economy where young people feel increasing uncertainty about housing, saving money and the cost of living, nearly two-thirds of Canadians under the age of 35 say they [...]
AnaCardio´s Phase 1b/2a GOAL-HF1 study in patients with Heart Failure and Reduced Ejection Fraction (HFrEF) published in The Lancet
25/06/2026
Favourable safety profile in marked contrast to traditional inotropic therapeutics AC01 showed rapid and sustained numerical improvements in cardiac output, structure and function STOCKHOLM, Sweden, June 25, 2026 – [...]
ProQR Announces Positive Phase 1 Target Engagement Data for AX-0810, Establishing First Clinical Validation of the Axiomer RNA Editing Platform
25/06/2026
Data from ongoing Phase 1 study of AX-0810 in healthy volunteers demonstrated dose-dependent target engagement on all key biomarkers in the evaluable 3 mg/kg and 6 mg/kg cohorts AX-0810 demonstrated up to 8-fold change [...]
BrewDog Inverurie Reopens with New Community Champions Model
25/06/2026
Opening set for Saturday 27 th June, featuring live music, entertainment and a sample pint on the house for the first 100 guests 1 New Community Champions model will support local initiatives, events, fundraising, [...]
DeepHealth Receives Two FDA Clearances Enabling it to Add Cardiovascular Insights and Prior Exam Integration to its AI-Powered Breast Suite
25/06/2026
New capabilities are designed to improve cancer detection and recall rates and enable physicians to make informed cardiovascular decisions SOMERVILLE, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- DeepHealth, Inc., a leader [...]
AtaiBeckley to Join the Russell Indexes, Expanding Visibility Across U.S. Equity Markets
25/06/2026
AtaiBeckley to be added to the Russell 2000® Index and the broad-market Russell 3000® Index as part of 2026 reconstitution The Russell U.S. Indexes have approximately $12.2 trillion in assets benchmarked Inclusion [...]
EMBARC Announces Its Intention to Collaborate with Insmed on Landmark Interventional Study Evaluating Disease Modification Potential of Brensocatib in Bronchiectasis
25/06/2026
Hannover, Germany, June 25, 2026 (GLOBE NEWSWIRE) -- EMBARC Announces Its Intention to Collaborate with Insmed on Landmark Interventional Study Evaluating Disease Modification Potential of Brensocatib in Bronchiectasis [...]
Un nouveau projet de l’ACE pour soutenir les ergothérapeutes diplômés à l’étranger au Canada
25/06/2026
OTTAWA, Ontario, 25 juin 2026 (GLOBE NEWSWIRE) -- Un nouvel effort national est en cours afin de mieux soutenir les ergothérapeutes formés à l’étranger (EFE) dans l'avancement de leur carrière au Canada. L’Association [...]
Herantis appoints experienced drug development expert Dr Juha Savola as Chief Medical Officer
25/06/2026
Brings more than 25 years of global drug development, regulatory and strategic leadership experience successfully guiding innovative therapies from clinical development through regulatory approval and commercialization [...]
ProQR Prices $50.0 Million Underwritten Registered Direct Offering and Concurrent Private Placement
25/06/2026
LEIDEN, Netherlands and CAMBRIDGE, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (“ProQR”), a clinical-stage biotechnology company dedicated to changing lives through transformative RNA [...]
IBA to install the first proton therapy center in Brazil in Rio de Janeiro
25/06/2026
Louvain-La-Neuve, Belgium, June 25, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment [...]
Press Release: Sanofi Foundation opens new chapter centered on future generations
25/06/2026
Sanofi Foundation opens new chapter centered on future generations Paris, June 2 5 , 2026 . The Sanofi Foundation is opening a new chapter with a strengthened commitment to children and young people, particularly those [...]
AnaCardio´s Phase 1b/2a GOAL-HF1 study in patients with Heart Failure and Reduced Ejection Fraction (HFrEF) published in The Lancet
25/06/2026
Favourable safety profile in marked contrast to traditional inotropic therapeutics AC01 showed rapid and sustained numerical improvements in cardiac output, structure and function STOCKHOLM, Sweden, June 25, 2026 – [...]

Pages